Jiangsu Cancer Institute & Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Nanjing China (1960)

Organization Overview

First Clinical Trial
2014
NCT02301208
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

FENG Ji-feng | He Xia | Jiangsu Cancer Institute & Hospital | Xiaoxiang Chen